This inventor holds 1 USPTO granted patent. Top assignee: Hovione Inter Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations by Carlos Manuel Alvarez Perez
Introduction
Carlos Manuel Alvarez Perez is a notable inventor based in Lisbon, Portugal. He has made significant contributions to the field of pharmaceutical processes, particularly in the purification of iohexol. His innovative approach has led to advancements in the preparation of this important compound.
Latest Patents
One of his key patents is titled "Process for the preparation of crystalline and solvent free iohexol." This invention focuses on an industrial process for the purification and removal of residual solvents from iohexol. The process involves suspending crystalline iohexol, which may contain residual solvents above 100 ppm, in a fluid with low solubility. This is followed by heating, filtration, and drying. The result is crystalline iohexol with no residual organic solvent above 100 ppm and an increased purity level. This patent highlights his commitment to improving pharmaceutical manufacturing processes.
Career Highlights
Carlos is currently employed at Hovione Inter Limited, a company known for its expertise in pharmaceutical development and manufacturing. His work at Hovione has allowed him to apply his innovative ideas in a practical setting, contributing to the company's reputation for quality and efficiency in drug production.
Collaborations
Throughout his career, Carlos has collaborated with esteemed colleagues such as Guido Du Boulay Villax and Alexandre Jose Ganchas De Carvalho. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Carlos Manuel Alvarez Perez is a distinguished inventor whose work in the purification of iohexol has made a significant impact in the pharmaceutical industry. His innovative processes and collaborations continue to drive advancements in drug manufacturing.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile